Yes, low-dose ketamine can provide meaningful relief for certain chronic pain conditions. By blocking NMDA receptors that drive central sensitization -- the process by which the nervous system amplifies pain signals -- ketamine can interrupt the cycle of chronic pain at its neurological source. The strongest evidence supports its use in neuropathic pain, complex regional pain syndrome (CRPS), and fibromyalgia, where conventional pain medications have often proven inadequate.
How Ketamine Addresses Chronic Pain
Chronic pain conditions frequently involve central sensitization, a state in which NMDA receptors in the spinal cord and brain become overactive, amplifying pain signals and making the nervous system hypersensitive. This is why many chronic pain patients experience pain that is disproportionate to any remaining tissue damage -- the nervous system itself has become part of the problem.
Ketamine is the most potent clinically available NMDA receptor antagonist. At sub-anesthetic doses, it blocks these overactive receptors, helping to "reset" abnormal pain processing. This mechanism is fundamentally different from opioids, which mask pain signals without addressing the underlying sensitization. Multiple clinical studies have demonstrated that ketamine infusions can reduce pain scores by 30 to 50 percent in patients with refractory neuropathic pain and CRPS.
Pain-Specific Dosing
Ketamine dosing for chronic pain often differs from depression protocols. While depression treatment uses a standard 0.5 mg/kg infusion over 40 minutes, pain protocols may employ lower-dose extended infusions -- such as 0.1 to 0.35 mg/kg per hour over 4 to 8 hours or even multi-day infusions in inpatient settings. These longer infusion protocols allow for sustained NMDA receptor blockade, which may be necessary to reverse established central sensitization. The optimal dosing protocol depends on the specific pain condition and its severity.
Analgesic effects from a single ketamine infusion can last days to weeks, with some CRPS patients reporting sustained improvement for months after a treatment course. However, as with depression treatment, most patients require repeated sessions to maintain benefit.
It is important to note that ketamine is not effective for all types of chronic pain. Nociceptive pain from ongoing tissue damage (such as active arthritis) may respond less consistently than neuropathic or centralized pain syndromes.
For a broader overview of ketamine therapy and its applications, see the Complete Guide to Low-Dose Ketamine Therapy.
References
- PubMed: Ketamine for Chronic Pain: A Comprehensive Review — Systematic review of ketamine efficacy across chronic pain conditions
- NIH: Chronic Pain Information — National Institute of Neurological Disorders and Stroke overview of chronic pain
- PubMed: NMDA Receptor Antagonists and Central Sensitization — Review of the role of NMDA receptors in chronic pain pathophysiology
Share